MRF - Looking for Melanoma patients using investigational therapies (e.g. Yervoy, PLX4032)

Have you been treated with an investigational melanoma therapy? We want to hear your story.

The Melanoma Research Foundation (MRF) is working with major U.S. news outlets to tell the story of patients with advanced melanoma who may be benefiting from the latest treatment advances. With the annual meeting of the American Society of Clinical Oncology approaching next week, the melanoma community is expecting new data on these treatments to generate media coverage. If you would like to share your story with reporters, please complete the survey below.

Specifically, we are looking for people who:

- Are living with advanced melanoma

- Have participated in a clinical trial for investigational drugs, including Ipilimumab (Yervoy), PLX4032 (vemurafenib) or other therapies

- Are available for media interviews (most likely by telephone, but people living in major cities may be invited to participate in a television interview if the opportunity arises)

If this describes you or someone you know, please let us know as soon as possible by completing the form below. We'll contact you if a reporter would like to set up an interview.

Thanks for your help! This is a great opportunity to bring more attention to the need for innovative treatment options for people with melanoma.

Question Title

Contact Information: Please include home and mobile numbers in the field below.

Name:

City/Town:

State:

Country:

Email Address:

Phone Number:

Question Title

How old are you?

Question Title

When were you diagnosed with advanced melanoma (month and year)?

Question Title

Have you participated in a clinical trial for an investigative melanoma therapy, including Ipilimumab (Yervoy), PLX4032 (vemurafenib) or any other drugs? When and where was the trial conducted?

MRF - Looking for Melanoma patients using investigational therapies (e.g. Yervoy, PLX4032)

Have you been treated with an investigational melanoma therapy? We want to hear your story.

Question Title

Contact Information: Please include home and mobile numbers in the field below.

Question Title

How old are you?

Question Title

When were you diagnosed with advanced melanoma (month and year)?

Question Title

Have you participated in a clinical trial for an investigative melanoma therapy, including Ipilimumab (Yervoy), PLX4032 (vemurafenib) or any other drugs? When and where was the trial conducted?

Question Title

Please briefly describe your experience with the clinical trial, and what the outcome was for you. Why do you feel compelled to tell this story?

Question Title

As Yervoy, PLX4032 and other therapies continue to be developed and brought to market, how will that impact your treatment decisions?

Question Title

Is there anything else you would like to share about your experience with investigational therapies for melanoma?